Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia.

Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia.
复制标题

治疗引起的鼠类成人T细胞白血病中白血病发射活性的选择性丧失。

DOI:
10.1084/jem.20101095
复制
发表时间:
2010-12-20
期刊:
The Journal of experimental medicine
影响因子:
--
通讯作者:
Bazarbachi A
Bazarbachi A
中科院分区:
其他
文献类型:
--
作者:
El Hajj H;El-Sabban M;Hasegawa H;Zaatari G;Ablain J;Saab ST;Janin A;Mahfouz R;Nasr R;Kfoury Y;Nicot C;Hermine O;Hall W;de Thé H;Bazarbachi A

文献摘要

参考文献

被引文献

相似文献

在成年T细胞白血病小鼠模型中,干扰素-α和三氧化二砷联合治疗可在减少原发肿瘤体积之前消除白血病起始活性慢性HTLV-I(人T细胞嗜淋巴细胞病毒I型)感染可导致成人T细胞白血病/淋巴瘤(ATL),一种长期预后不良的疾病。HTLV-I反式激活因子Tax在转基因小鼠中启动ATL。在这项研究中,我们证明了As 2 O3和IFN-α的组合,已知触发Tax蛋白水解,治愈小鼠Tax驱动的ATL。出乎意料的是,这种联合治疗取消了最初的白血病移植到第二个受体,而原发肿瘤块仍然在原发宿主中生长,最终只是后来减弱。最近,一种类似的方案在人类ATL中取得了前所未有的疾病控制。我们证明,这种靶向Tax稳定性的药物组合消除了肿瘤细胞的永生性,但不是短期生长,这可能预示着这种方案在患者中的长期有效性。
Treatment with a combination of interferon-α and arsenic trioxide ablates leukemia-initiating activity before reducing primary tumor bulk in a murine model of adult T cell leukemia. Chronic HTLV-I (human T cell lymphotropic virus type I) infection may cause adult T cell leukemia/lymphoma (ATL), a disease with dismal long-term prognosis. The HTLV-I transactivator, Tax, initiates ATL in transgenic mice. In this study, we demonstrate that an As2O3 and IFN-α combination, known to trigger Tax proteolysis, cures Tax-driven ATL in mice. Unexpectedly, this combination therapy abrogated initial leukemia engraftment into secondary recipients, whereas the primary tumor bulk still grew in the primary hosts, only to ultimately abate later on. This loss of initial transplantability required proteasome function. A similar regimen recently yielded unprecedented disease control in human ATL. Our demonstration that this drug combination targeting Tax stability abrogates tumor cell immortality but not short-term growth may foretell a favorable long-term efficiency of this regimen in patients.
DOI: 10.1038/sj.thj.6200374
发表时间: 2004-01-01
期刊: HEMATOLOGY JOURNAL
影响因子: --
作者:
Hermine, O;Dombret, H;Bazarbachi, A
通讯作者: Bazarbachi, A
DOI: 10.1182/blood-2009-03-211821
发表时间: 2009-06-25
期刊: BLOOD
影响因子: 20.3
作者:
Kchour, Ghada;Tarhini, Mahdi;Bazarbachi, Ali
通讯作者: Bazarbachi, Ali
DOI: 10.1038/nature07567
发表时间: 2008-12-04
期刊: NATURE
影响因子: 64.8
作者:
Quintana, Elsa;Shackleton, Mark;Sabel, Michael S.;Fullen, Douglas R.;Johnson, Timothy M.;Morrison, Sean J.
通讯作者: Morrison, Sean J.
DOI: 10.1182/blood-2005-09-3572
发表时间: 2006-05-15
期刊: BLOOD
影响因子: 20.3
作者:
Nasr, Rihab;Chiari, Estelle;Bazarbachi, Ali
通讯作者: Bazarbachi, Ali
全反式视黄酸/三氧化二砷治疗新诊断的急性早幼粒细胞白血病的长期疗效和安全性。
DOI: 10.1073/pnas.0813280106
发表时间: 2009-03-03
影响因子: 11.1
作者:
Hu, Jiong;Liu, Yuan-Fang;Chen, Zhu
通讯作者: Chen, Zhu